BPI Theater @ BIO 2023

Featured on BPI Theater @ BIO 2023

BioProcess Insider Interview: Min Park, Chief Business Officer, Aton Biotech
Sponsored Content
BioProcess Insider Interview: Min Park, Chief Business Officer, Aton BiotechBioProcess Insider Interview: Min Park, Chief Business Officer, Aton Biotech

byBPI Contributor
Aug 21, 2023
How Emerging Technology Is Improving the Cell Therapy Manufacturing Landscape
Sponsored Content
How Emerging Technology Is Improving the Cell Therapy Manufacturing LandscapeHow Emerging Technology Is Improving the Cell Therapy Manufacturing Landscape
byBPI Contributor
Aug 21, 2023
Advancing Data Driven Drug Discovery
Sponsored Content
Advancing Data Driven Drug DiscoveryAdvancing Data Driven Drug Discovery
byBPI Contributor
Aug 21, 2023
Enabling and Accelerating Innovative- and Emerging- Modalities Drug Discovery Through a Global Open Platform
Sponsored Content
Enabling and Accelerating Innovative- and Emerging- Modalities Drug Discovery Through a Global Open PlatformEnabling and Accelerating Innovative- and Emerging- Modalities Drug Discovery Through a Global Open Platform
byBPI Contributor
Aug 21, 2023
Continuous Manufacturing for Better Access: A Paradigm Shift in Biologics
Sponsored Content
Continuous Manufacturing for Better Access: A Paradigm Shift in BiologicsContinuous Manufacturing for Better Access: A Paradigm Shift in Biologics
byBPI Contributor
Aug 21, 2023
Advances in Protein A Chromatography Resins
Sponsored Content
Advances in Protein A Chromatography ResinsAdvances in Protein A Chromatography Resins
byBPI Contributor
Aug 21, 2023

More from BPI Theater @ BIO 2023

The Secrets of Ensuring a Successful Process Validation Campaign at a CDMO
Sponsored Content
The Secrets of Ensuring a Successful Process Validation Campaign at a CDMO
The Secrets of Ensuring a Successful Process Validation Campaign at a CDMO
Aug 21, 2023
byBPI Contributor
One-Stop, Integrated Viral-Vector Platform for Speed to Clinic
Sponsored Content
One-Stop, Integrated Viral-Vector Platform for Speed to Clinic
One-Stop, Integrated Viral-Vector Platform for Speed to Clinic
Aug 21, 2023
byBPI Contributor
Build it Right: A Quality Perspective on the Design and Build of a Viral Vector CDMO Manufacturing Facility
Sponsored Content
Build it Right: A Quality Perspective on the Design and Build of a Viral Vector CDMO Manufacturing Facility
Build it Right: A Quality Perspective on the Design and Build of a Viral Vector CDMO Manufacturing Facility
Aug 21, 2023
byBPI Contributor
The Next Generation of Emerging Therapies and Technologies
Sponsored Content
The Next Generation of Emerging Therapies and Technologies
The Next Generation of Emerging Therapies and Technologies
Aug 21, 2023
byBPI Contributor
How Did the Pandemic Adjust the CDMO Landscape, and How Will This Sector Change Moving Forward?
Sponsored Content
How Did the Pandemic Adjust the CDMO Landscape, and How Will This Sector Change Moving Forward?
How Did the Pandemic Adjust the CDMO Landscape, and How Will This Sector Change Moving Forward?
Aug 21, 2023
+3
byS Anne Montgomery, Rich Richieriand 3 more
Adoption of New Biopharmaceutical Technologies: Case Studies from the Front Line
Sponsored Content
Adoption of New Biopharmaceutical Technologies: Case Studies from the Front Line
Adoption of New Biopharmaceutical Technologies: Case Studies from the Front Line
Aug 21, 2023
+3
byTom Ransohoff, Aaron Larsenand 3 more
BioProcess Insider Interview: Michael Schrader, Chief Executive Officer and Cofounder, Vaxess Technologies
Sponsored Content
BioProcess Insider Interview: Michael Schrader, Chief Executive Officer and Cofounder, Vaxess Technologies
BioProcess Insider Interview: Michael Schrader, Chief Executive Officer and Cofounder, Vaxess Technologies
Aug 21, 2023
byBPI Contributor
BioProcess Insider Interview: Hayley Crowe, Senior Vice President, Purolite
Sponsored Content
BioProcess Insider Interview: Hayley Crowe, Senior Vice President, Purolite
BioProcess Insider Interview: Hayley Crowe, Senior Vice President, Purolite
Aug 21, 2023
byBPI Contributor
BioProcess Insider Interview: Andrew Mears, Chief Executive Officer, Lead Candidate
Sponsored Content
BioProcess Insider Interview: Andrew Mears, Chief Executive Officer, Lead Candidate
BioProcess Insider Interview: Andrew Mears, Chief Executive Officer, Lead Candidate
Aug 21, 2023
byBPI Contributor
BioProcess Insider Interview: Luis Berrade, Senior Director, Biologics Testing Solutions, Charles River Laboratories
Sponsored Content
BioProcess Insider Interview: Luis Berrade, Senior Director, Biologics Testing Solutions, Charles River Laboratories
BioProcess Insider Interview: Luis Berrade, Senior Director, Biologics Testing Solutions, Charles River Laboratories
Aug 21, 2023
byBPI Contributor
BioProcess Insider Interview: Darren Head, Chief Executive Officer, Bionova Scientific
Sponsored Content
BioProcess Insider Interview: Darren Head, Chief Executive Officer, Bionova Scientific
BioProcess Insider Interview: Darren Head, Chief Executive Officer, Bionova Scientific
Aug 21, 2023
byBPI Contributor
BioProcess Insider Interview: Emmanuel Ligner, Chief Executive Officer, Cytiva
Sponsored Content
BioProcess Insider Interview: Emmanuel Ligner, Chief Executive Officer, Cytiva
BioProcess Insider Interview: Emmanuel Ligner, Chief Executive Officer, Cytiva
Aug 21, 2023
byBPI Contributor

Webinars

WuXi Biologics slide 1
Sponsored Content
Advanced Analytical Strategies: From Protein Structure Characterization to Potency Assessment for Challenging Biologic ModalitiesAdvanced Analytical Strategies: From Protein Structure Characterization to Potency Assessment for Challenging Biologic Modalities
Thermo Fisher/AstraZeneca webinar title slide
Sponsored Content
Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROs Mixed-Mode Chromatography MediaManufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROs Mixed-Mode Chromatography Media
Scorpius Biomanufacturing
Sponsored Content
The Rapidly Evolving Landscape of Contract Biologics ManufacturingThe Rapidly Evolving Landscape of Contract Biologics Manufacturing
Insider News
See all
Sep 23 - Sep 26, 2024
Learn from the brightest minds in bioprocessing! The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.
Learn More

Innovative Technology

thumbnail
Sponsored Content
Single-Use Upstream Processing: Ultimus® Film Delivers Comparable Cell Growth Performance To GlassSingle-Use Upstream Processing: Ultimus® Film Delivers Comparable Cell Growth Performance To Glass
byBPI Contributor
Jul 24, 2024
1 Min Read
Lonza Fab Vial Hands
Sponsored Content
A Comprehensive and Flexible Approach to CMC for Fab and Fc-Fusion Development ProgramsA Comprehensive and Flexible Approach to CMC for Fab and Fc-Fusion Development Programs
byBPI Contributor
Jul 15, 2024
1 Min Read
Emerson Practical Guide
Sponsored Content
A Practical Guide to Optimizing Your Drug Manufacturing Process in Increasingly Demanding EnvironmentsA Practical Guide to Optimizing Your Drug Manufacturing Process in Increasingly Demanding Environments
byBPI Contributor
Jul 3, 2024
1 Min Read